Lower adalimumab trough levels are associated with higher bowel wall thickness in Crohn's disease

BACKGROUND: In Crohn's disease, higher adalimumab trough levels and negative anti-adalimumab-antibodies associate with better clinical and endoscopic outcomes. Intestinal ultrasound has become a relevant non-invasive method to monitor treatment. However, data on the association between adalimum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Ungar, Bella, Ben-Shatach, Zohar, Selinger, Limor, Malik, Alona, Albshesh, Ahmad, Ben-Horin, Shomron, Eliakim, Rami, Kopylov, Uri, Carter, Dan
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7079273/
https://ncbi.nlm.nih.gov/pubmed/32213067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619878974
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados